30
CARDIOVASCULAR
hamburger

Implant Confidently

The Regent™ aortic mechanical valve offers surgeon-friendly implantability, featuring a low valve implant height that helps ensure coronary ostia clearance. Two distinct cuff types—FlexCuff™ or Standard Cuff—provide you with different options. The Regent™ valve features exceptional hemodynamics in small aortic root patients.1*

Because prosthesis-patient mismatch (PPM) can be problematic in the aortic position, Abbott designed the Regent™ valve specifically to avoid this issue. The orifice-to-annulus ratio of the Regent™ valve ensures large effective orifice areas (EOAs) and reduces PPM.2

The Regent™ valve shows low thromboembolism, thrombosis, and bleeding over a wide international normalized ratio (INR) range, making this valve an excellent choice.3-6

*Measured one year post-surgery.

Learn about the features of the Regent™ Aortic Mechanical Heart Valve.

Regent Aortic

Confidently Implant the Most Trusted Mechanical Valves in the World.

Learn more about the Regent™ Aortic Mechanical Heart Valve by visiting the Abbott Structural Heart website

Ordering Information

Regent™ Aortic Mechanical Heart Valve
Catalog Number Tissue Annulus Diameter (mm) Geometric Orifice Area (cm²) Implant Height Open (mm) Overall Height Open (mm) Cuff Outer Diameter (mm)
Standard Cuff
19 AGN-751 19 2.4 6.1 11.6 24.7
21 AGN-751 21 2.9 7.3 13.0 26.7
23 AGN-751 23 3.5 8.0 14.3 28.7
25 AGN-751 25 4.0 8.2 14.6 30.7
27 AGN-751 27 4.7 9.1 15.4 32.7
29 AGN-751 29 5.4 9.5 16.5 34.7
FlexCuff™
19 AGFN-756 19 2.4 6.1 11.6 27.0
21 AGFN-756 21 2.9 7.3 13.0 29.0
23 AGFN-756 23 3.5 8.0 14.3 31.0
25 AGFN-756 25 4.0 8.2 14.6 33.0
27 AGFN-756 27 4.7 9.1 15.4 35.0
29 AGFN-756 29 5.4 9.5 16.5 37.0

References

  1. Regent PMA Supplement.
  2. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol. 2000;36(4):1131-1141. doi.org/10.1016/s0735-1097(00)00859-7.
  3. Bach DS, Sakwa MP, Goldbach M, et al. Hemodynamics and early clinical performance of the St. Jude Medical Regent mechanical aortic valve. Ann Thorac Surg. 2002;74(6):2003-2009.
  4. Torella M, Torella D, Chiodini P, et al. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. Am Heart J. 2010;160(1); 171-178. doi: 10.1016/j.ahj.2010.05.005
  5. Koertke H, Zittermann A, Wagner O, et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Ann Thorac Surg. 2010;90(5):1487-1493.
  6. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg. 2005;79(3):776-82. doi: 10.1016/j.athoracsur.2004.08.047

MAT-2011658 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.